XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
STOCKHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

5. STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

The Company has authorized 10,000,000 shares of preferred stock. These shares may be issued in series with such rights and preferences as may be determined by the board of directors.

 

Series A Convertible Redeemable Preferred Stock

 

The Company’s Board of Directors has authorized 2,000,000 shares of $2.00 stated value, Series A Preferred Stock. The preferred stock has a senior liquidation preference value of $2.00 per share and does not bear dividends.

 

As of December 31, 2023, and 2022, the Company has 200,500 shares of Series A Preferred Stock outstanding.

 

Series D Convertible Preferred Stock

 

The Company has established a class of preferred stock designated “Series D Convertible Preferred Stock” (Series D preferred stock) and authorized an aggregate of 1,000,000 non-voting shares with a stated value of $1.00 per share. Holders of the Series D preferred stock are entitled to receive dividends at the annual rate of 8% based on the stated value per share computed on the basis of a 360-day year and twelve 30-day months. Dividends are cumulative, shall be declared quarterly, and are calculated from the date of issue and payable on the 15th day of April, July, October, and January. The dividends may be paid, at the option of the holder either in cash or by the issuance of shares of the Company’s common stock valued at the market price on the dividend record date. Shares of the Series D preferred stock are redeemable at the Company’s option. At the option of the holder, shares of the Series D preferred stock plus any declared and unpaid dividends are convertible to shares of the Company’s common stock at a conversion rate of $1.00 per share.

 

As of December 31, 2023, and 2022, the Company had 375,000 shares of Series D Preferred Stock outstanding.

 

For years ended December 31, 2023, and 2022, the Company declared $30,000 and $30,000 in preferred dividends, respectively. During the years ended December 31, 2023, and 2022, the Company paid $6,900 and $30,000, respectively, for Series D preferred stock dividends. Dividends declared of $7,500 were accrued as of December 31, 2021, were paid in 2022. Declared dividends of $7,500 were accrued as of December 31, 2022 and were paid in 2023.

 

Common Stock

 

The Company’s Board of Directors has authorized 50,000,000 shares of $0.05 par value, Common Stock. As of December 31, 2023, and 2022, the Company has 3,054,587 shares of common stock outstanding, respectively.

 

 

There were no repurchases performed in the 2023 year.

 

Common Stock Warrants

 

As of December 31, 2023, and December 31, 2022, the Company had 177,500 and 206,000, respectively, of outstanding warrants to purchase common stock at a weighted average exercise price of $5.00 and $5.00, respectively, and weighted average remaining term of 0.5 years and 1.67 years, respectively. The aggregate intrinsic value of common stock warrants outstanding as of December 31, 2023, and December 31, 2022 was $0.

 

   Year Ended December 31, 
   2023   2022 
   Number of   Weighted Average   Number of   Weighted Average 
   Warrants   Exercise Price   Warrants   Exercise Price 
                 
Beginning Balance   206,000   $5.00    206,000   $5.00 
Issued   177,500    -    -    - 
Cancelled   -    -    -    - 
Exercised   -    -    -    - 
Expired   (206,000)   -    -    - 
                     
Ending Balance   177,500   $5.00    206,000   $5.00 

 

Common Stock Options

 

On January 6, 2022, the Company issued a three-year option to purchase 30,000 shares of our common stock at $6.00 per share. As of December 31, 2023 and December 31, 2022, the Company had a total of 30,000 outstanding options to purchase common stock. The aggregate intrinsic value of common stock options outstanding as of December 31, 2023, and December 31, 2022 was $0.

  

   Year Ended December 31, 
   2023   2022 
   Number of   Weighted Average   Number of   Weighted Average 
   Options   Exercise Price   Options   Exercise Price 
                 
Beginning Balance   30,000   $6.00    30,000   $6.00 
Issued   -    -    -    - 
Cancelled   -    -    -    - 
Exercised   -    -    -    - 
Expired   -    -    -    - 
                     
Ending Balance   30,000   $6.00    30,000   $6.00